Bandingkan Harga & Kinerja Bank Danamon Indonesia Tbk (BDMN) vs Brigit Biofarmaka Teknologi Tbk. (OBAT)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Bank Danamon Indonesia Tbk dan Brigit Biofarmaka Teknologi Tbk.: Bank Danamon Indonesia Tbk diperdagangkan di Rp4.300 (kapitalisasi pasar 41,61 T), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp242 (kapitalisasi pasar 164,65 M). Perbedaan utamanya: Bank Danamon Indonesia Tbk jauh lebih besar — sekitar 252,7× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| BDMN | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 41,61 T | 164,65 M |
Harga Ekuilibrium Indikatif | 4.310 | 242 |
Volume Ekuilibrium Indikatif | 2 | 5 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Bank Danamon Indonesia Tbk
Bank Danamon (the Bank) domiciled in Jakarta, was established on July 16, 1956, based on the notarial deed No. 134 of Meester Raden Soedja, S.H. The Bank received its permit as a commercial bank the following September 1956, and became a foreign exchange bank in November 1988. During the Asian Financial crisis of 1997, Bank Danamon ran into a liquidity insolvency and was taken over by the government of Indonesia in April 1998, which placed in the care of the Indonesian Bank Restructuring Agency (IBRA) to be included in the bank recapitalization and merger programs. Following a third rights issue by Bank Danamon and the subsequent merging of Bank PDFCI into the Bank on December 30, 1999; the racapitalizaton of Bank Danamon which increased its statutory capital To Rp 10 trillion on May 17, 2000; and the merging of eight private banks (Bank Jaya, Bank Tiara Asia, Bank Pos Nusntara, Bank Rama, Bank Tamara, Bank Nusa Nasional, Bank Duta and Bank Bank Risjad Salim International) into Bank Danamon on June 30, 2000; Bank Danamon re-emerged as one of Indonesia’s four designated core banks along with Bank Central Asia in the private sector, and with Bank andiri and Bank BNI in the Public sector.
Selengkapnya di halaman BDMN →Tentang Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →
